Al Altomari, Chairman & CEO of Agile Therapeutics AGRX was recently a guest on Benzinga’s All Access.
Agile Therapeutics is a women’s healthcare company “dedicated to fulfilling the unmet needs of today’s women.” The company looks to develop novel treatments for women's health needs.
Agile’s flagship product, Twirla®, is a once-weekly birth control patch. The patch uses proprietary technology called Skinfusion®. The patch allows for freedom from the pill burden of traditional pill forms.
Watch the full interview here:
Featured photo by Emma Simpson on Unsplash.
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
